Concerns about side effects are one of the most common reasons men hesitate to try ED medication. The good news: PDE5 inhibitors — the standard treatment for erectile dysfunction — have been used by hundreds of millions of men worldwide since 1998, and their safety profile is well-established.
This guide covers what to expect, what's genuinely concerning, and what's a myth.
A systematic review of PDE5 inhibitor trials confirmed that the most frequently reported side effects are mild, transient, and dose-related:
| Side Effect | Sildenafil | Tadalafil | Notes |
|---|---|---|---|
| Headache | ~16% | ~15% | Most common; usually resolves in a few hours |
| Flushing | ~10% | ~3% | Warmth/redness in face and neck |
| Dyspepsia | ~7% | ~11% | Mild stomach discomfort |
| Nasal congestion | ~4% | ~3% | Stuffy nose |
| Visual disturbance | ~3% | Rare | Blue tinge (sildenafil); PDE6 cross-reactivity |
| Back pain | Rare | ~6% | Tadalafil-specific; PDE11 cross-reactivity |
| Myalgia | Rare | ~5% | Muscle aches; tadalafil-specific |
Sources: Goldstein et al., Fink et al., Hatzimouratidis
These percentages come from clinical trials where every symptom is meticulously recorded. In real-world use, many men experience no notable side effects at all. Among those who do, most describe them as tolerable and short-lived.
Side effects tend to be more pronounced at higher doses and often diminish with continued use as your body adjusts.
Sildenafil has mild cross-reactivity with PDE6, an enzyme found in the retina. This can cause: - A slight blue or blue-green tinge to vision - Increased sensitivity to light - Blurred vision
These effects are temporary and resolve as the drug clears your system (within 4–6 hours). They occur in roughly 3% of users and are more common at higher doses.
Facial flushing is more pronounced with sildenafil than tadalafil. It's caused by vasodilation (blood vessel relaxation) — the same mechanism that treats ED. It's harmless but can be cosmetically noticeable.
Back pain (~6%) and myalgia (~5%) are the distinguishing side effects of tadalafil. They are thought to result from PDE11 cross-reactivity in skeletal muscle. Key characteristics:
An erection lasting more than 4 hours that does not resolve. This is a medical emergency — if untreated, it can cause permanent tissue damage. Seek emergency medical attention immediately. Priapism is extremely rare with PDE5 inhibitors.
Extremely rare reports of non-arteritic anterior ischaemic optic neuropathy (NAION) and sudden sensorineural hearing loss have been associated with PDE5 inhibitor use. If you experience sudden vision loss in one or both eyes, or sudden hearing loss, stop the medication and seek immediate medical attention.
PDE5 inhibitors cause modest, transient decreases in blood pressure. For most men, this is clinically insignificant. However, the combination with nitrate medications is dangerous (see below).
This is the single most important safety message about ED medications.
PDE5 inhibitors must never be taken with nitrate drugs, which are used to treat angina (chest pain). The combination causes severe, potentially fatal hypotension (blood pressure drop).
Common nitrate medications include: - Nitroglycerin (sublingual tablets, patches, sprays) - Isosorbide mononitrate - Isosorbide dinitrate - Amyl nitrite ("poppers") — a recreational drug
If you use any nitrate medication, PDE5 inhibitors are not an option. If you experience chest pain after taking a PDE5 inhibitor, inform emergency medical staff that you have taken the medication so they do not administer nitrates.
Beyond nitrates, discuss these with your prescriber:
In men without contraindications (particularly nitrate use), PDE5 inhibitors have a reassuring cardiovascular safety profile. They do not increase the risk of heart attack or stroke. In fact, the modest blood pressure reduction they cause is actually similar to that of some blood pressure medications.
PDE5 inhibitors have no pharmacological dependence potential. You will not experience withdrawal symptoms if you stop taking them. Some men develop psychological reliance ("I can't perform without it"), which is best addressed through counselling — not a property of the drug itself.
The opposite tends to be true. Many side effects diminish with repeated use as your body adapts to the medication.
Reach out to your prescribing doctor if:
It depends on the severity and stability of your condition, and which cardiac medications you take. PDE5 inhibitors are safe for many men with stable cardiovascular disease — but the nitrate contraindication is absolute. Your doctor will assess your individual risk.
No. Generic medications contain the same active ingredient at the same dose. Side effect profiles are identical.
Often yes. Many men report that headaches diminish or disappear after several uses. Taking the medication with food or paracetamol can help manage headache in the interim.
PDE5 inhibitors can generally be used alongside SSRIs and other antidepressants, but some antidepressants themselves cause ED. Discuss with your doctor to determine the best approach — adjusting your antidepressant may also be considered.
Seek medical attention. Symptoms of overdose may include severe headache, dizziness, fainting, or prolonged erection. Do not take more than the prescribed dose.
PDE5 inhibitor side effects are well-studied, generally mild, and typically short-lived. The most important safety rule is simple: never combine with nitrate medications. Beyond that, the vast majority of men tolerate ED medication well. An open conversation with your doctor — disclosing all medications and medical conditions — is the foundation of safe use.
Related articles: - [The Complete Guide to ED Treatment in Hong Kong (HK-N-ED-EN-P1)] - [Viagra vs Cialis (HK-N-ED-EN-01)] - [Sildenafil Guide (HK-N-ED-EN-02)] - [Tadalafil Guide (HK-N-ED-EN-03)]
: Goldstein I, et al. Oral sildenafil in the treatment of erectile dysfunction. N Engl J Med. 1998;338(20):1397-1404. PMID: 9580646 : Tsertsvadze A, Fink HA, et al. Sildenafil for male erectile dysfunction: a systematic review and meta-analysis. Ann Intern Med. 2009;151(9):650-661. PMID: 19884626 : Hatzimouratidis K, Hatzichristou DG. Phosphodiesterase type 5 inhibitors: the day after. Eur Urol. 2007;51(1):75-88. PMID: 16949200
This article is for informational purposes only. Always consult a licensed doctor for medical advice.
© noah™ All rights reserved.

